Aerocrine: BlueCross BlueShield of Florida Continues Trend, Retires Negative ... Business Wire (press release) We will be better able to identify patients who will respond to inhaled corticosteroids and even determine in whom we may be able to decrease the doses of asthma controller medications” Aerocrine AB (NASDAQ OMX NORDIC: AERO)(STO:AEROB) announces that ... |
